Derrick Hasenour
Family Medicine · Franklin, INNPI 1295997450
Payments from drug & device makers
Across 115 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$362
- Lilly USA, LLC$204
- Amgen$162
- GSK$123
- Merck$94
- Exact Sciences$93
- plus $862 from 24 others
What the payments were for
- Food & beverage$1,78594%
- Education$1166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $362 |
| Lilly USA, LLC | 14 | $204 |
| Amgen | 11 | $162 |
| GSK | 9 | $123 |
| Merck | 6 | $94 |
| Exact Sciences | 5 | $93 |
| AbbVie | 3 | $86 |
| Novartis | 5 | $82 |
| Bayer | 4 | $56 |
| AstraZeneca | 4 | $52 |
| Abbott | 3 | $50 |
| Cranial Technologies, Inc | 3 | $43 |
| Sanofi Pasteur Inc. | 3 | $41 |
| Dexcom, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Boehringer Ingelheim | 2 | $31 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Corium, LLC | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Tris Pharma Inc | 2 | $26 |
| Pfizer | 2 | $25 |
| Johnson & Johnson | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$116
How this compares
$1,901 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 191 | $228,661 |
| OzempicSemaglutide | 93 | $115,239 |
| FarxigaDapagliflozin Propanediol | 110 | $114,520 |
| JardianceEmpagliflozin | 71 | $95,111 |
| Repatha SureclickEvolocumab | 54 | $57,285 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $51,795 |
| TrulicityDulaglutide | 29 | $43,540 |
| EliquisApixaban | 20 | $32,069 |
| OxycontinOxycodone Hcl | 37 | $30,494 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $23,153 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $15,666 |
| Xigduo XrDapaglifloz Propaned/Metformin | 15 | $15,230 |
| LinzessLinaclotide | 19 | $14,968 |
| XareltoRivaroxaban | 12 | $14,917 |
| MyrbetriqMirabegron | 17 | $11,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $204 | $272,201220 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $52 | $137,673136 claims |
| Novo NordiskOzempic | $362 | $115,23993 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $31 | $100,76282 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arexvy, Arnuity Ellipta | $123 | $85,234110 claims |
| PfizerEliquis | $25 | $32,06920 claims |
| AbbVieLinzess | $86 | $14,96819 claims |
| Johnson & JohnsonXarelto | $20 | $14,91712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Franklin
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.